A historic shift in Canadian drug policy has occurred, as the government announce the legalization of psilocybin hallucinogens for therapeutic applications. Previously, these substances were strictly restricted, but a growing body of evidence suggests they could offer benefits for mental health illnesses like anxiety. This change represents a subst